These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19491629)

  • 1. Changes of red blood cell surface markers in a blood doping model of neocytolysis.
    Chang CC; Chen Y; Modi K; Awar O; Alfrey C; Rice L
    J Investig Med; 2009 Jun; 57(5):650-4. PubMed ID: 19491629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The negative regulation of red cell mass by neocytolysis: physiologic and pathophysiologic manifestations.
    Rice L; Alfrey CP
    Cell Physiol Biochem; 2005; 15(6):245-50. PubMed ID: 16037689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell senescence and neocytolysis in humans after high altitude acclimatization.
    Risso A; Turello M; Biffoni F; Antonutto G
    Blood Cells Mol Dis; 2007; 38(2):83-92. PubMed ID: 17188915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiological aspects of red blood cells in end-stage renal disease patients resistant to recombinant human erythropoietin therapy.
    Georgatzakou HT; Tzounakas VL; Kriebardis AG; Velentzas AD; Papageorgiou EG; Voulgaridou AI; Kokkalis AC; Antonelou MH; Papassideri IS
    Eur J Haematol; 2017 Jun; 98(6):590-600. PubMed ID: 28295628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neocytolysis: none, one or many? A reappraisal and future perspectives.
    Risso A; Ciana A; Achilli C; Antonutto G; Minetti G
    Front Physiol; 2014; 5():54. PubMed ID: 24592241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin withdrawal alters interactions between young red blood cells, splenic endothelial cells, and macrophages: an in vitro model of neocytolysis.
    Trial J; Rice L; Alfrey CP
    J Investig Med; 2001 Jul; 49(4):335-45. PubMed ID: 11478410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neocytolysis on descent from altitude: a newly recognized mechanism for the control of red cell mass.
    Rice L; Ruiz W; Driscoll T; Whitley CE; Tapia R; Hachey DL; Gonzales GF; Alfrey CP
    Ann Intern Med; 2001 Apr; 134(8):652-6. PubMed ID: 11304105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of red cell mass by neocytolysis in space and on Earth.
    Rice L; Alfrey CP
    Pflugers Arch; 2000; 441(2-3 Suppl):R91-4. PubMed ID: 11200988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin test methods.
    Breymann C
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Mar; 14(1):135-45. PubMed ID: 10932816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients.
    Gallucci MT; Lubrano R; Meloni C; Morosetti M; Manca di Villahermosa S; Scoppi P; Palombo G; Castello MA; Casciani CU
    Clin Nephrol; 1999 Oct; 52(4):239-45. PubMed ID: 10543326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIF-mediated increased ROS from reduced mitophagy and decreased catalase causes neocytolysis.
    Song J; Yoon D; Christensen RD; Horvathova M; Thiagarajan P; Prchal JT
    J Mol Med (Berl); 2015 Aug; 93(8):857-66. PubMed ID: 26017143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of neocytolysis for optimal management of anaemia in chronic kidney disease.
    Alfrey CP; Fishbane S
    Nephron Clin Pract; 2007; 106(4):c149-56. PubMed ID: 17596723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of EPO injections using a rapid lateral flow isoform test.
    Lönnberg M; Lundby C
    Anal Bioanal Chem; 2013 Dec; 405(30):9685-91. PubMed ID: 23657454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single dose of acetylsalicylic acid in patients with Type 2 diabetes mellitus and/or chronic renal failure ameliorates anaemia by decreasing the rate of neocytolysis.
    Wittmann I; Molnár GA; Wagner L; Köszegi T; Wagner Z; Laczy B; Tamaskó M; Markó L; Mohás M; Nagy J
    Acta Physiol Hung; 2007 Mar; 94(1-2):159-66. PubMed ID: 17444284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered red cell and platelet adhesion in hemolytic diseases: Hereditary spherocytosis, paroxysmal nocturnal hemoglobinuria and sickle cell disease.
    Sakamoto TM; Canalli AA; Traina F; Franco-Penteado CF; Gambero S; Saad ST; Conran N; Costa FF
    Clin Biochem; 2013 Dec; 46(18):1798-803. PubMed ID: 24060729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neocytolysis contributes to the anemia of renal disease.
    Rice L; Alfrey CP; Driscoll T; Whitley CE; Hachey DL; Suki W
    Am J Kidney Dis; 1999 Jan; 33(1):59-62. PubMed ID: 9915268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin withdrawal leads to the destruction of young red cells at the endothelial-macrophage interface.
    Trial J; Rice L
    Curr Pharm Des; 2004; 10(2):183-90. PubMed ID: 14754397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red cell survival: relevance and mechanism involved.
    Handelman GJ; Levin NW
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S84-8. PubMed ID: 20797578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neocytolysis: physiological down-regulator of red-cell mass.
    Alfrey CP; Rice L; Udden MM; Driscoll TB
    Lancet; 1997 May; 349(9062):1389-90. PubMed ID: 9149714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The quantification of reticulocyte maturation and neocytolysis in normal and erythropoietin stimulated rats.
    Wiczling P; Krzyzanski W; Zychlińska N; Lewandowski K; Kaliszan R
    Biopharm Drug Dispos; 2014 Sep; 35(6):330-40. PubMed ID: 24888906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.